Agios Pharmaceuticals Inc
(STU:8AP)
€
39.4
0.2 (0.51%)
Market Cap: 2.40 Bil
Enterprise Value: 1.90 Bil
PE Ratio: 0
PB Ratio: 3.45
GF Score: 42/100 - Q1 2024 Agios Pharmaceuticals Inc Earnings Call TranscriptMay 02, 2024€31.4 (+3.29%)Earnings
- Q4 2023 Agios Pharmaceuticals Inc Earnings Call TranscriptFeb 15, 2024€24 (+3.45%)Earnings
- Agios Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Agios Pharmaceuticals Inc ENERGIZE Phase 3 Topline Results TranscriptJan 03, 2024
- Q3 2023 Agios Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2023€19.8 (-1.00%)Earnings
- Agios Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Agios Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2023€23.6 (-0.84%)Earnings
- Agios Pharmaceuticals Inc to Review the Rise up Phase 2 Data and next Steps for the Phase 3 Portion of the Study Call TranscriptJun 26, 2023
- Agios Pharmaceuticals Inc at Goldman Sachs Healthcare Conference TranscriptJun 15, 2023
- Q1 2023 Agios Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2023€20.6 (+0.98%)Earnings
- Q4 2022 Agios Pharmaceuticals Inc Earnings Call TranscriptFeb 23, 2023€24.8Earnings
- Agios Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Agios Pharmaceuticals Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Q3 2022 Agios Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2022€28.2 (+3.68%)Earnings
- Agios Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Agios Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2022€24.4 (+7.96%)Earnings
- Agios Pharmaceuticals Inc Leadership Update TranscriptJul 12, 2022
- Agios Pharmaceuticals Inc Investor Event (Virtual) TranscriptJun 13, 2022
- Q1 2022 Agios Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2022€22.6 (+2.73%)Earnings
- Q4 2021 Agios Pharmaceuticals Inc Earnings Call TranscriptFeb 24, 2022€25.11 (-0.95%)Earnings
- Agios Pharmaceuticals Inc to Discuss the FDA Approval of PYRUKYND Call TranscriptFeb 18, 2022
- Agios Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2022
- Agios Pharmaceuticals Inc to Host Investor Webcast TranscriptDec 14, 2021
- Agios Pharmaceuticals Inc Investor Day TranscriptNov 17, 2021
- Q3 2021 Agios Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2021€42.66 (+0.54%)Earnings
- Agios Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2021
- Q2 2021 Agios Pharmaceuticals Inc Earnings Call TranscriptJul 29, 2021€42.19 (-1.47%)Earnings
- Agios Pharmaceuticals Inc to Present Mitapivat Clinical Data at EHA Virtual Congress TranscriptJun 11, 2021
- Q1 2021 Agios Pharmaceuticals Inc Earnings Call TranscriptApr 29, 2021€45.83 (+0.79%)Earnings
- Agios Pharmaceuticals Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 17, 2021
- Agios Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Q4 2020 Agios Pharmaceuticals Inc Earnings Call TranscriptFeb 25, 2021€41.56 (-4.42%)Earnings
- Agios Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Agios Pharmaceuticals Inc Investor Relations Event TranscriptDec 21, 2020
- Agios Pharmaceuticals Inc Virtual Investor Event to Review Data Presented at ASH TranscriptDec 08, 2020
- Agios Pharmaceuticals Inc at Piper Sandler Healthcare Conference (Virtual) TranscriptDec 02, 2020
- Agios Pharmaceuticals Inc Webinar on Pyruvate Kinase-R (PKR) Activation Clinical Programs and Commercial Outlook TranscriptNov 19, 2020
- Q3 2020 Agios Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020€35.2 (-2.95%)Earnings
- Agios Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2020
- Agios Pharmaceuticals Inc at Canaccord Genuity Growth Conference (Virtual) TranscriptAug 13, 2020
- Q2 2020 Agios Pharmaceuticals Inc Earnings Call TranscriptJul 30, 2020€40.62 (-4.27%)Earnings
- Agios Pharmaceuticals Inc at BMO Capital Markets Prescription for Success Healthcare Conference (Virtual) TranscriptJun 23, 2020
- Agios Pharmaceuticals Inc Virtual Investor Webcast to Review Mitapivat Clinical Data Presented at EHA Annual Congress TranscriptJun 12, 2020
- Agios Pharmaceuticals Inc at RBC Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- Q1 2020 Agios Pharmaceuticals Inc Earnings Call TranscriptApr 30, 2020€39.35 (-4.65%)Earnings
- Agios Pharmaceuticals Inc at Cowen HealthCare Conference TranscriptMar 03, 2020
- Agios Pharmaceuticals Inc at Leerink Global Healthcare Conference TranscriptFeb 25, 2020
- Q4 2019 Agios Pharmaceuticals Inc Earnings Call TranscriptFeb 13, 2020€44.62 (-0.18%)Earnings
- Agios Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Agios Pharmaceuticals Inc Investor Event to Review Data Presented at ASH TranscriptDec 10, 2019
- Q3 2019 Agios Pharmaceuticals Inc Earnings Call TranscriptOct 31, 2019€26.73 (-4.12%)Earnings
- Agios Pharmaceuticals Inc Investor Event to Review AG-270 Phase 1 Data and Research TranscriptOct 27, 2019
- Agios Pharmaceuticals Inc to Discuss Data from ClarIDHy Study Presented at ESMO - Conference Call TranscriptSep 30, 2019
- Agios Pharmaceuticals Inc at Citi Biotech Conference TranscriptSep 05, 2019
- Q2 2019 Agios Pharmaceuticals Inc Earnings Call TranscriptAug 01, 2019€39.55 (-8.60%)Earnings
- Agios Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- Q1 2019 Agios Pharmaceuticals Inc Earnings Call TranscriptMay 02, 2019€45.86 (-8.09%)Earnings
- Agios Pharmaceuticals Inc at Cowen Health Care Conference TranscriptMar 11, 2019
- Agios Pharmaceuticals Inc at Leerink Partners Global Healthcare Conference TranscriptFeb 28, 2019
- Q4 2018 Agios Pharmaceuticals Inc Earnings Call TranscriptFeb 14, 2019€48.46 (+0.04%)Earnings
Agios Pharmaceuticals Inc Virtual Investor Webcast to Review Mitapivat Clinical Data Presented at EHA Annual Congress Transcript
Jun 12, 2020 / 11:30AM GMT
Release Date Price:
€43.15
(-4.70%)
Kendra Adams
Agios Pharmaceuticals, Inc. - VP of External Communications & IR
Good morning, everyone. We're going to get started here. I'm going to turn it over to Jackie. For our sell-side friends, if you have not e-mailed myself or Holly and would like to get in the lineup for the Q&A, will you just shoot us an e-mail now and we'll take questions as folks have e-mailed us and then queued up. So with that, Jackie, why don't I turn it over to you? Jackie, we can't hear you just make sure you're unmuted.
Jacqualyn A. Fouse
Agios Pharmaceuticals, Inc. - CEO & Director
Can you hear me?
Kendra Adams
Agios Pharmaceuticals, Inc. - VP of External Communications & IR
Part of it. Thank you. Yes, go ahead.
Jacqualyn A. Fouse
Agios Pharmaceuticals, Inc. - CEO & Director
Everybody. Can I get some thumbs up that you can hear me. Okay. Perfect. Thank you. Good morning, everybody. Why don't I to start off our e virtual investor webcast this morning. So thanks
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)